Founders building diagnostics

At-home vaginal microbiome diagnostics and care pathways.

Molecular diagnostics for prenatal and family-planning testing.

AI-powered prenatal ultrasound for fetal cardiac defects.

Menstrual-blood-based endometriosis diagnostics.

AI-assisted breast cancer detection for radiologists.

Rapid STI diagnostic tests.

AI-powered at-home breast cancer screening.

Modernized breast imaging infrastructure.

Urine-based diagnostics (PHASIFY) for PCOS, endometriosis, gynecologic cancers.

Multi-omic AKRIVIS GD blood test for early-stage ovarian cancer detection.

Synbiotic and probiotic platform; gut-health support.

Public continuous-glucose-monitoring company (NASDAQ: DXCM); CGM adoption expanding into metabolic and GLP-1 use cases.

At-home test kits across hormones, thyroid, fertility, STI, food sensitivity.

At-home lab tests with clinical follow-up; hormones, fertility, sexual health.

At-home testing across targeted biomarkers with peer-reviewed methodology.

Gut microbiome and RNA-based health testing with personalized recommendations.

Gut microbiome testing for families with clinical coaching.

Blood biomarkers + DNA + wearables in one personalized dashboard.

Frequent at-home blood monitoring across ~60 biomarkers with AI insights.

Annual broad blood snapshot across ~100 biomarkers, twice-yearly testing.

Public AI-driven precision medicine and diagnostics platform (NASDAQ: TEM).